Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Certificate of Incorporation of the Company, Effective on May 14, 2019
- 3.2 Amended and Restated Certificate of Incorporation of the Company, Effective on May 15, 2019
- 3.3 Bylaws of the Company, Effective As of May 15, 2019
- 10.1 Amended and Restated Registration Rights Agreement Dated May 15, 2019
- 10.4 Escrow Agreement Dated May 13, 2019
- 10.7 Indemnification Agreement
- 14.1 Insider Trading Policy
- 17.1 Resignation of Peixin Xu
- 21.1 Subsidiaries of Registrant
- 99.1 Audited Financial Statements of Xynomic Pharmaceuticals, Inc.
- 99.2 Pro Forma Financial Statements
- 99.3 Press Release Dated May 15, 2019
XYNPW similar filings
Filing view
External links
Exhibit 21.1
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
SUBSIDIARIES OF THE REGISTRANT
Name of Subsidiary | Jurisdiction of Incorporation or Organization | |
Xynomic Pharmaceuticals, Inc. | Delaware | |
Xynomic Pharmaceuticals (Nanjing) Co., Ltd | People’s Republic of China | |
Xynomic Pharmaceuticals (Shanghai) Co., Ltd | People’s Republic of China | |
Xynomic Pharmaceuticals (Zhongshan) Co., Ltd | People’s Republic of China |